Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Takumi Anraku
Comparison of Combined Tofogliflozin and Glargine, Tofogliflozin Added to Insulin, and Insulin Dose-Increase Therapy in Uncontrolled Type 2 Diabetes
Journal of Clinical Medicine Research
Related publications
An Indirect Treatment Comparison of the Efficacy of Insulin Degludec/Liraglutide (IDegLira) and Insulin Glargine/Lixisenatide (iGlarLixi) in Patients With Type 2 Diabetes Uncontrolled on Basal Insulin
Journal of Medical Economics
Health Policy
Efficacy and Safety of LY2963016 Insulin Glargine in Patients With Type 1 and Type 2 Diabetes Previously Treated With Insulin Glargine
Diabetes, Obesity and Metabolism
Internal Medicine
Endocrinology
Metabolism
Diabetes
Cost-Effectiveness of Insulin Degludec Compared With Insulin Glargine for Patients With Type 2 Diabetes Mellitus Initiating Insulin Therapy in the United Kingdom
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Superior Efficacy of Insulin Degludec/Liraglutide Versus Insulin Glargine U100 as Add-On to Sodium-Glucose Co-Transporter-2 Inhibitor Therapy: A Randomized Clinical Trial in Patients With Uncontrolled Type 2 Diabetes
Diabetes, Obesity and Metabolism
Internal Medicine
Endocrinology
Metabolism
Diabetes
Insulin Glargine/Lixisenatide in Type 2 Diabetes: A Profile of Its Use
Drugs and Therapy Perspectives
Pharmacology
Fasting and Insulin Glargine in Individuals With Type 1 Diabetes
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
In Silico Head-To-Head Comparison of Insulin Glargine 300 U/Ml and Insulin Degludec 100 U/Ml in Type 1 Diabetes
Diabetes Technology and Therapeutics
Medicine
Endocrinology
Medical Laboratory Technology
Metabolism
Diabetes
Correction To: Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults With Type 2 Diabetes: Focus on Lixisenatide and Insulin Glargine
Advances in Therapy
Medicine
Pharmacology
New Meta-Analysis of Patient-Level Data on Efficacy and Hypoglycaemia With Insulin Glargine or NPH Insulin in Type 2 Diabetes Mellitus (T2DM) According to Concomitant Oral Therapy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental